Assisted reproduction and choice in the biotech age: recommendations for a way forward
By Francine Coeytaux, Marcy Darnovsky, Susan Berke Fogel,
Contraception
| 01. 01. 2011
[Editorial]
To view the PDF version of this article, please scroll down to the bottom of this page.
Over the past several decades, millions of people have used new reproductive technologies in their quest for biologically related children. Access to these technologies has enabled people who suffer from infertility, same-sex couples and single women to form biological families. At the same time, these tools can be used to select the sex of a future child [1] or to “de-select” based on a growing number of genetic markers for disabilities and other conditions [2]. While assisted reproductive technologies have increased parental options for those who can afford them, they pose numerous ethical challenges that the reproductive rights, health and justice communities are only beginning to address.
The assisted reproduction field has so far developed largely outside the realm of public policy and with little public discussion about how new technologies should be used and who should have access to them. Difficult questions have had minimal public airing. Should access to reproductive technologies be limited to those who can pay for them? Should...
Related Articles
By Kristine Servando, Bloomberg | 12.05.2024
(Bloomberg) — A woman in Hong Kong had to travel to two different countries to attempt conceiving a baby on her own. A gay couple in the city resorted to even bigger extremes: Banned from surrogacy, they turned to the...
By Sarojini Nadimpally and Gargi Mishra, The Wire | 12.15.2024
In-vitro fertilisation (IVF) as assisted reproductive technology (ART) has been in vogue for quite a few decades now. While IVF has been hailed as a significant scientific advancement, with many advantages, here are some limitations which bear keeping in mind...
By Natalie Obiko Pearson, Jessica Brice, Susan Berfield, Vernon Silver, Kanoko Matsuyama, Cindy Wang, Sinduja Rangarajan, Fani Nikiforaki, Bloomberg | 12.12.2024
A single cell.
A global business worth billions.
A trade that can bring rewards—or human costs that cannot be measured.
The human egg is a precious resource, exchanged in markets open, gray or black. To tell its story, we follow...
By Michelle LePage, TorontoMet Today | 12.13.2024
As more people access fertility services in their journeys to becoming parents, Toronto Metropolitan University professor Katie Hammond says the Canadian fertility industry is in need of greater oversight.
A professor at the Lincoln Alexander School of Law, Hammond’s latest...